TR200500749T2 - Dna mutajenik hasarının tamiri - Google Patents
Dna mutajenik hasarının tamiriInfo
- Publication number
- TR200500749T2 TR200500749T2 TR2005/00749T TR200500749T TR200500749T2 TR 200500749 T2 TR200500749 T2 TR 200500749T2 TR 2005/00749 T TR2005/00749 T TR 2005/00749T TR 200500749 T TR200500749 T TR 200500749T TR 200500749 T2 TR200500749 T2 TR 200500749T2
- Authority
- TR
- Turkey
- Prior art keywords
- repair
- mutagenic damage
- dna mutagenic
- methods
- damage
- Prior art date
Links
- 231100000219 mutagenic Toxicity 0.000 title abstract 2
- 230000003505 mutagenic effect Effects 0.000 title abstract 2
- ZZUBHVMHNVYXRR-UHFFFAOYSA-N 3-(4-hydroxyphenyl)-2h-chromen-7-ol Chemical compound C1=CC(O)=CC=C1C1=CC2=CC=C(O)C=C2OC1 ZZUBHVMHNVYXRR-UHFFFAOYSA-N 0.000 abstract 2
- CNNBJLXLTIKXGJ-UHFFFAOYSA-N 3-phenyl-2h-chromene Chemical compound C1OC2=CC=CC=C2C=C1C1=CC=CC=C1 CNNBJLXLTIKXGJ-UHFFFAOYSA-N 0.000 abstract 1
- 208000000453 Skin Neoplasms Diseases 0.000 abstract 1
- ADFCQWZHKCXPAJ-GFCCVEGCSA-N equol Chemical compound C1=CC(O)=CC=C1[C@@H]1CC2=CC=C(O)C=C2OC1 ADFCQWZHKCXPAJ-GFCCVEGCSA-N 0.000 abstract 1
- 235000019126 equol Nutrition 0.000 abstract 1
- ADFCQWZHKCXPAJ-UHFFFAOYSA-N indofine Natural products C1=CC(O)=CC=C1C1CC2=CC=C(O)C=C2OC1 ADFCQWZHKCXPAJ-UHFFFAOYSA-N 0.000 abstract 1
- NNQSGBRGJHSRFN-UHFFFAOYSA-N isoflavan Chemical class C1OC2=CC=CC=C2CC1C1=CC=CC=C1 NNQSGBRGJHSRFN-UHFFFAOYSA-N 0.000 abstract 1
- 201000000849 skin cancer Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2002951271A AU2002951271A0 (en) | 2002-09-06 | 2002-09-06 | Repair of dna mutagenic damage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200500749T2 true TR200500749T2 (tr) | 2005-10-21 |
Family
ID=27671591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2005/00749T TR200500749T2 (tr) | 2002-09-06 | 2003-09-05 | Dna mutajenik hasarının tamiri |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20060153781A1 (https=) |
| EP (1) | EP1534232A4 (https=) |
| JP (1) | JP2006501252A (https=) |
| CN (1) | CN1688285A (https=) |
| AU (1) | AU2002951271A0 (https=) |
| CA (1) | CA2497823A1 (https=) |
| CZ (1) | CZ2005136A3 (https=) |
| MX (1) | MXPA05002519A (https=) |
| NO (1) | NO20051605D0 (https=) |
| TR (1) | TR200500749T2 (https=) |
| WO (1) | WO2004022023A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104643057A (zh) | 2002-07-24 | 2015-05-27 | 儿童医院医疗中心 | 含有对映体牛尿酚的组合物和产物及其用途 |
| US8668914B2 (en) | 2002-07-24 | 2014-03-11 | Brigham Young University | Use of equol for treating skin diseases |
| WO2004039327A2 (en) | 2002-10-29 | 2004-05-13 | Colorado State University Research Foundation | Use of equol for treating androgen mediated diseases |
| EP1542654A4 (en) * | 2002-09-23 | 2008-12-17 | Novogen Res Pty Ltd | TREATMENT OF PHOTOTATIOOD AND ACTINIC DETERIORATION OF THE SKIN |
| US8580846B2 (en) | 2002-10-29 | 2013-11-12 | Brigham Young University | Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders |
| CA2738510A1 (en) * | 2008-07-30 | 2010-02-04 | Novogen Research Pty Ltd | 6-substituted isoflavonoid compounds and uses thereof |
| HRP20240793T1 (hr) | 2018-04-18 | 2024-09-13 | Constellation Pharmaceuticals, Inc. | Modulatori enzima koji modificiraju metil, njihovi pripravci i upotreba |
| EP3797108B1 (en) | 2018-05-21 | 2022-07-20 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
| LT4003532T (lt) | 2019-07-24 | 2024-11-11 | Constellation Pharmaceuticals, Inc. | 7-chlor-2- (4-(3-metoksiazetidin-1-il)cikloheksil)-2,4-dimetil-n-((6-metil-4-(metiltio)-2-okso-1,2-dihidropiridin-3-il)metil)benzo[d][1,3]dioksol-5-karboksamido kristalinės formos |
| CN114831981A (zh) * | 2021-02-02 | 2022-08-02 | 上海交通大学 | 一种ERβ选择性激动剂在抗肿瘤中的应用 |
| CN117599041B (zh) * | 2024-01-22 | 2024-05-03 | 中国人民解放军军事科学院军事医学研究院 | 去氢雌马酚及其衍生物作为新型辐射防护剂和细胞保护剂的医药用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPO203996A0 (en) * | 1996-08-30 | 1996-09-26 | Novogen Research Pty Ltd | Therapeutic uses |
| AUPP112497A0 (en) * | 1997-12-24 | 1998-01-22 | Novogen Research Pty Ltd | Compositions and method for protecting skin from UV induced immunosupression and skin damage |
| AUPP868599A0 (en) * | 1999-02-15 | 1999-03-11 | Novogen Research Pty Ltd | Production of isoflavone derivatives |
| DE10121375B4 (de) * | 2001-05-02 | 2014-01-16 | Beiersdorf Ag | Verwendung von Isoflavonoiden in kosmetischen oder dermatologischen Zubereitungen zur Prophylaxe vor und Behandlung von sensibler Haut |
| DE10122342A1 (de) * | 2001-05-09 | 2002-11-14 | Beiersdorf Ag | Verwendung von Isoflavonen in kosmetischen oder dermatologischen Zubereitungen |
-
2002
- 2002-09-06 AU AU2002951271A patent/AU2002951271A0/en not_active Abandoned
-
2003
- 2003-09-05 EP EP03793484A patent/EP1534232A4/en not_active Withdrawn
- 2003-09-05 JP JP2004533066A patent/JP2006501252A/ja active Pending
- 2003-09-05 CN CNA038240114A patent/CN1688285A/zh active Pending
- 2003-09-05 CA CA002497823A patent/CA2497823A1/en not_active Abandoned
- 2003-09-05 TR TR2005/00749T patent/TR200500749T2/xx unknown
- 2003-09-05 US US10/526,830 patent/US20060153781A1/en not_active Abandoned
- 2003-09-05 CZ CZ20050136A patent/CZ2005136A3/cs unknown
- 2003-09-05 MX MXPA05002519A patent/MXPA05002519A/es active IP Right Grant
- 2003-09-05 WO PCT/AU2003/001152 patent/WO2004022023A1/en not_active Ceased
-
2005
- 2005-03-30 NO NO20051605A patent/NO20051605D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20051605L (no) | 2005-03-30 |
| NO20051605D0 (no) | 2005-03-30 |
| EP1534232A4 (en) | 2008-12-24 |
| CZ2005136A3 (cs) | 2006-04-12 |
| AU2002951271A0 (en) | 2002-09-19 |
| EP1534232A1 (en) | 2005-06-01 |
| CN1688285A (zh) | 2005-10-26 |
| JP2006501252A (ja) | 2006-01-12 |
| CA2497823A1 (en) | 2004-03-18 |
| WO2004022023A1 (en) | 2004-03-18 |
| US20060153781A1 (en) | 2006-07-13 |
| MXPA05002519A (es) | 2005-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL164249A0 (en) | Acyl-3-carboxphenylurea derivatives, processes forpreparing them and their use | |
| TW200507484A (en) | An ultra-wideband transceiver architecture and associated methods | |
| BR0300840B1 (pt) | conjunto de conduto protetor. | |
| MXPA05013822A (es) | Pirrolodihidroisoquinolinas utiles en el tratamiento del cancer. | |
| TR200500749T2 (tr) | Dna mutajenik hasarının tamiri | |
| ATE553185T1 (de) | Expressionskassette und vektor zur transienten oder stabilen expression exogener moleküle | |
| WO2001096606A3 (en) | Identification of genes and compounds for treatment of cancer | |
| CA101715S (en) | Multiple-bladed thicket knife | |
| MXPA03008076A (es) | Isoflavonas dimericas. | |
| HUE052154T2 (hu) | Rövid felezési idejû C1 inhibitor tranziens kezeléshez | |
| DK1599205T3 (da) | PTEN-inhibitor eller Maxi-K-kanalåbner | |
| DE50303356D1 (de) | Gasgenerator | |
| WO2004031402A3 (en) | Methylation profile of cancer | |
| NO20020357D0 (no) | Antenneanordning | |
| DE50304273D1 (de) | Gasgenerator | |
| WO2003065997A3 (en) | Anti-infarction molecules | |
| ES1052858Y (es) | Tensor terminal de elementos filiformes en general. | |
| EA200600609A1 (ru) | Производные имидазопиридина в качестве ингибиторов индуцируемой no-синтазы | |
| FI20031392L (fi) | Hakkuri- tai murskainlaitteisto, erityisesti lastuhakkuri | |
| DE60335525D1 (de) | 2,3-Diaryl-Pyrazolidine Derivate als Neurotensin abbauende Enzyme-Inhibitoren | |
| DE60319388D1 (de) | C6- UND C9-SUBSTITUIERTE CHROMENOÄ4,3-cÜISOXAZOLIN | |
| NO20044186L (no) | Peptid-deformylaseinhibitorer | |
| NO20053188D0 (no) | Fremgangsmate og anordning for multibruker interferenskansellering. | |
| ATE264308T1 (de) | Aminoalkyl-3,4-dihydrochinolin-derivate als no synthase inhibitoren | |
| NO20054289D0 (no) | Imiciazo[4,5-b]kinolinderivater og dem anvendelse som NO-syntaseinhibitorer |